?Tolvaptan Sodium Phosphate API | V2 Antagonist for SIADH & Hyponatremia Treatment | China | Manufacturer

Price	Get Latest Price
Package	1g	10g

Product Details

Product Name: Tolvaptan Sodium Phosphate	CAS No.: 942619-79-6
Min. Order: 1g	Purity: 0.99
Supply Ability: 50kg	Release date: 2025/06/20

‌Tolvaptan Sodium Phosphate (CAS 942619-79-6)‌
🌟 ‌ChemicalBook Product Profile‌

📌 ‌Product Overview‌

‌Tolvaptan Sodium Phosphate‌ (C₂₆H₂₇ClN₂NaO₆P), a ‌phosphate prodrug of Tolvaptan‌, is a potent ‌vasopressin V2 receptor antagonist‌ with a molecular weight of ‌552.92 g/mol‌. This ‌white crystalline powder‌ (≥99.5% purity, HPLC validated) is designed for ‌intravenous diuretic therapy‌, particularly for patients with fluid retention who cannot tolerate oral medications. It hydrolyzes in vivo to release Tolvaptan, which selectively inhibits water reabsorption in renal tubules, promoting electrolyte-sparing diuresis. Available in ‌1g/5g/100g‌ sealed aluminum foil packaging with ‌3-year stability‌ under dry, light-protected conditions.

‌Google Keywords‌: Tolvaptan Sodium Phosphate CAS 942619-79-6, V2 Antagonist API Supplier, High-Purity Diuretic Intermediate, GMP-Certified Pharma Raw Material

✅ ‌Key Advantages‌

🔹 ‌Ultra-High Purity‌

≥99.5% purity (HPLC/NMR validated) | Complies with ‌EP/USP/CP‌ standards.
🔹 ‌GMP-Certified Manufacturing‌
Produced in ‌ISO 9001‌ and ‌GMP-compliant facilities‌ | REACH and ICH stability compliant.
🔹 ‌Rapid Therapeutic Action‌
Achieves peak plasma concentration within ‌2-4 hours‌ post-administration.

🏥 ‌Application Fields‌

‌Diuretic Formulations‌: Core API for IV therapies targeting hyponatremia and heart failure-related edema.
‌Clinical Research‌: Key intermediate in developing vasopressin receptor antagonists.
‌Pharma Bulk Supply‌: Supports global production of specialty diuretics.

📜 ‌Quality Certifications‌

‌Analytical Methods‌: HPLC, NMR, mass spectrometry, microbial limit testing.
‌Certifications‌: ‌GMP‌, ‌ISO 9001‌, ‌REACH‌, and ‌ICH Q1-Q12 guidelines‌.

📊 ‌Market Trends‌

The ‌global diuretics market‌ is projected to grow at ‌5.8% CAGR (2025-2030)‌, driven by rising cardiovascular disorders and demand for targeted renal therapies. Tolvaptan derivatives dominate ‌35% of the vasopressin antagonist segment‌, with Asia-Pacific emerging as the primary API production hub.

📩 ‌Contact us for COA, bulk orders, and custom synthesis!

Article illustration

Company Profile Introduction

Wuhan Biocar Pharmaceutical Co., Ltd. is a high-tech and innovative enterprise specializing in the research, development, production, and sales of APIs and pharmaceutical intermediates (excluding finished drugs). Located in the heart of Optics Valley Biological City, our company leverages the cutting-edge facilities of the Wuhan University Scientific Research Laboratory and benefits from the region's favorable policies to advance the field of biomedicine. Guided by our business philosophy—"Driven by market demand, powered by technological innovation, and enabled by e-commerce"—we are committed to delivering biomedical products that are precise, high-quality, fast, and reliable. Our offerings serve pharmaceutical companies, university research institutions, hospital outpatient services, reagent providers, and distributors worldwide.

Recommended supplier

Product name	Price		Suppliers	Update time
Tolvaptan	$75.00/1kg	VIP2Y	Zibo Hangyu Biotechnology Development Co., Ltd	2024-03-15
Tolvaptan	$0.00/1kg	VIP3Y	Enki Biopharmaceuticals (Shanghai) Limited	2023-11-26
Sodium Phosphate	$3.60/1kg	VIP1Y	Hebei Andu Technology Com.,Ltd	2024-07-30
Tolvaptan Sodium Phosphate	$0.00/1kg	VIP1Y	Hebei Junhua Import and Export Co., LTD	2025-04-07

Tolvaptan Sodium Phosphate